Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Nucleic Acid Therapeutics Market (Product Type: RNA interference (RNAi) and Short Interfering RNAs, Antisense Oligonucleotides (ASOs), and Others; and Application: Autoimmune Disorders, Infectious Diseases, Genetic Disorders, Cancer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Growth, Trends, and Forecast, 2024-2034 Nucleic Acid Therapeutics Market – Scope of Report TMR’s report on the global nucleic acid therapeutics market studies the past as well as the current growth trends and opportunities to ... Read More
-
Global Autologous Cell Therapy Market Size Study, by Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Others), by Source (Bone Marrow, Peripheral Blood, Adipose Tissue, Others), by End-Use (Hospitals, Academics & Research, Others), and Regional Forecasts 2022-2032
... Others), and Regional Forecasts 2022-2032 The Global Autologous Cell Therapy Market is valued approximately at USD 4.32 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 22.20% over ... Read More
-
IVD Contract Research Organization Market - forecast to 2033 : By SERVICE TYPE (Clinical Chemistry, Immunochemistry, Hematology, Histology and Cytology, Microbiology, Molecular Diagnostics, Genetic Testing, Others), THERAPEUTIC AREA (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Disorders, Autoimmune Disorders, Metabolic Diseases, Others), END USER (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical, Biotechnology, Others), PHASE OF DEVELOPMENT (Preclinical, Clinical Phase I, Clinical Phase II, Clinical Phase III, Post-market Surveillance), PRODUCT TYPE (Reagents & Kits, Instruments, Services, Software), TECHNOLOGY (Polymerase Chain Reaction, Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Next-Generation Sequencing, Microarrays, Flow Cytometry, Others), APPLICATION (Infectious Disease Testing, Cancer Diagnosis, Cardiovascular Disease Testing, Diabetes Testing, Autoimmune Disease Testing, Blood Screening, Others), TYPE OF S
... Autoimmune Disorders, Metabolic Diseases, Others), END USER (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical, Biotechnology, Others), PHASE OF DEVELOPMENT (Preclinical, Clinical Phase I, Clinical Phase II, Clinical Phase III, Post-market Surveillance), PRODUCT TYPE (Reagents ... Read More
-
Intravenous Immunoglobulin (IVIg)
... by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. IgA, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$13.7 Billion by the ... Read More
-
Autoimmune Disease Therapeutics
... by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Anti-inflammatory Drug Class, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$183.0 Billion ... Read More
-
Primary Sjogren's Syndrome - Global Clinical Trials Review, 2024
... of Primary Sjogren's Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Sjogren's Syndrome. Report includes an overview of trial numbers and their average enrollment in top ... Read More
-
Global Autoimmune Hemolytic Anemia Therapeutics Market 2024-2028
... on the autoimmune hemolytic anemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Global Celiac Diseases Drugs Market 2024-2028
... celiac diseases drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Epidermal Growth Factors (EGFs) Market (Type of EGFs: TGF-alpha, Amphiregulin, Epiregulin, Betacellulin, and Others, and Application: Skincare Products, Wound Healing, cancer Therapy, Autoimmune Disorders, Regenerative Medicine, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Trends, and Forecast, 2024-2034 Epidermal Growth Factors (EGFs) Market – Scope of Report TMR’s report on the global epidermal growth factors (EGFs) market studies the past as well as the current growth trends and opportunities ... Read More
-
Hydroxychloroquine Market Size, Trends, Analysis, and Outlook By Product (Tablet, Active Pharmaceutical Ingredients), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Drug Store), By Disease (Malaria, Rheumatoid Arthritis, Lupus Erythematosus, Coronavirus, Others), by Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global Hydroxychloroquine market size is poised to register a 7.2% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The Hydroxychloroquine market study ... Read More
-
Cutaneous Lupus Erythematosus Market by Clinical Presentation (Acute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus, Subacute Cutaneous Lupus Erythematosus), Drug Class (Antimalarial Drugs, Corticosteroids, Immunosuppressants), Route
... USD 2.07 billion in 2023 and expected to reach USD 2.26 billion in 2024, at a CAGR 9.72% to reach USD 3.96 billion by 2030. Cutaneous lupus erythematosus (CLE) is a kind of lupus that ... Read More
-
Human Microbiome Market by Disease (Acute Diarrhea, Autoimmune Disorders, Cancer), Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools), Product, Therapeutic Area, Application - Global Forecast 2024-2030
... USD 1.58 billion in 2023 and expected to reach USD 1.96 billion in 2024, at a CAGR 23.90% to reach USD 7.11 billion by 2030. The human microbiome is the collective genomes of the microorganisms ... Read More
-
RNA Interference Technology Market by Type (dsRNA, miRNA, siRNA), Therapeutics (Autoimmune Hepatitis, Hepatitis B and C, Neurological Disorders), Application - Global Forecast 2024-2030
... in 2023 and expected to reach USD 39.25 billion in 2024, at a CAGR 22.38% to reach USD 135.40 billion by 2030. The RNA interference (RNAi) technology market encompasses systems that use small RNA molecules ... Read More
-
Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029
... to reach USD 901 million in 2029 from USD 579 million in 2024, at a CAGR of 9.2% during the forecast period. The growth of this market can be attributed to the increasing prevalence of ... Read More
-
Esoteric Testing Market Size, Share & Trends by Type (Endocrinology, Oncology, Neurology, Genetic Tests, Autoimmune, Infectious Diseases), Technology (ELISA, CLIA, Flow Cytometry, NGS, RT-PCR, Chromatography, Spectrometry), Specimen (Blood, Urine) - Global Forecast to 2029
... global esoteric testing market is valued at an estimated USD 32.2 billion in 2024 and is projected to reach USD 48.3 billion by 2029, at a CAGR of 8.5% during the forecast period. Growth in ... Read More
-
Autoimmune Hepatitis – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Autoimmune Hepatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Autoimmune Hepatitis market report provides current treatment practices, emerging drugs, Autoimmune ... Read More
-
Global Kinase Inhibitor in Autoimmune Diseases – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the Global Kinase Inhibitor in Autoimmune Diseases, historical and forecasted epidemiology as well as the Global Kinase Inhibitor in Autoimmune Diseases market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
-
Autoimmune Encephalitis – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Autoimmune Encephalitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Autoimmune Encephalitis market report provides current treatment practices, emerging drugs, Autoimmune ... Read More
-
Palmoplantar Pustulosis (PPP) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Palmoplantar Pustulosis (PPP) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Palmoplantar Pustulosis (PPP) market report provides current ... Read More
-
Autoimmune gastritis – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Autoimmune gastritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Autoimmune gastritis market report provides current treatment practices, emerging drugs, Autoimmune ... Read More
-
Allogeneic T-cell therapy for autoimmune diseases – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the Allogeneic T-cell therapy for autoimmune diseases, historical and forecasted epidemiology as well as the Allogeneic T-cell therapy for autoimmune diseases market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
-
Liver Disease Therapeutic Market Report by Therapy Type (Anti-Rejection Drugs/Immunosuppressants, Chemotherapy Drugs, Targeted therapy, Vaccines, Immunoglobulins, Corticosteroids, and Anti-Viral Drugs) Disease Type (Non-alcoholic Fatty Liver Disease (NAFLD), Viral Hepatitis (B, C, D), Alcoholic Liver Disease (ALD), and Autoimmune Liver Disease (ALD)) End Users (Hospitals, Laboratories, and Others) Regions and Company Analysis 2024-2032
... (ALD), and Autoimmune Liver Disease (ALD)) End Users (Hospitals, Laboratories, and Others) Regions and Company Analysis 2024-2032 The market for Liver Disease Therapeutics is predicted to reach US$ 28.98 billion in 2032, increasing at a ... Read More
-
Antiphospholipid Syndrome (APS) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Antiphospholipid Syndrome (APS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Antiphospholipid Syndrome (APS) market report provides current ... Read More
-
Systemic Lupus Erythematosus Market Insight, Epidemiology And Market Forecast - 2034
... drug applications submitted to the US FDA for cancer therapies are successful, and for brain cancer, the rate of success has been closer to 1% over the past two decades. Currently, there is an estimation ... Read More
-
Adult-onset Still Disease – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Adult-onset Still Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Adult-onset Still Disease market report provides current ... Read More
Research Assistance
